CD82 and cancer: Our previous studies indicate that CD82 negatively controls cancer cell migration and proteinase secretion by regulating cell signalling events, particularly those mediated by receptor tyrosine kinase (RTK) and phosphoinositide 3-kinase (PI3K) (25,31,32).